Globe Life Inc. (NYSE:GL – Get Free Report) CEO James Matthew Darden sold 24,890 shares of Globe Life stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $121.52, for a total value of $3,024,632.80. Following the sale, the chief executive officer now owns 38,973 shares of the company’s stock, valued at approximately $4,735,998.96. This trade represents a 38.97 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Globe Life Trading Down 1.4 %
Shares of NYSE:GL opened at $121.80 on Friday. The company has a market cap of $10.22 billion, a P/E ratio of 10.19 and a beta of 0.81. The company has a debt-to-equity ratio of 0.50, a current ratio of 0.05 and a quick ratio of 0.05. Globe Life Inc. has a 1 year low of $38.95 and a 1 year high of $132.00. The stock’s fifty day moving average price is $114.66 and its 200-day moving average price is $107.98.
Globe Life (NYSE:GL – Get Free Report) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $3.14 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.12 by $0.02. Globe Life had a return on equity of 22.32% and a net margin of 18.53%. Sell-side analysts expect that Globe Life Inc. will post 13.57 earnings per share for the current year.
Institutional Inflows and Outflows
Wall Street Analysts Forecast Growth
A number of analysts have recently issued reports on GL shares. Morgan Stanley lifted their price target on Globe Life from $123.00 to $125.00 and gave the company an “equal weight” rating in a research report on Tuesday. Truist Financial lifted their price target on Globe Life from $90.00 to $105.00 and gave the stock a “hold” rating in a research note on Friday, October 25th. Piper Sandler lifted their price objective on Globe Life from $118.00 to $130.00 and gave the stock an “overweight” rating in a research report on Friday, October 25th. Keefe, Bruyette & Woods lifted their price objective on Globe Life from $137.00 to $145.00 and gave the stock an “outperform” rating in a research report on Wednesday. Finally, Jefferies Financial Group lifted their price target on Globe Life from $107.00 to $114.00 and gave the company a “hold” rating in a research report on Tuesday, December 10th. Five analysts have rated the stock with a hold rating, five have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $133.10.
Get Our Latest Research Report on GL
About Globe Life
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
See Also
- Five stocks we like better than Globe Life
- How to buy stock: A step-by-step guide for beginners
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- The Significance of Brokerage Rankings in Stock Selection
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- Insider Trading – What You Need to Know
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Globe Life Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Globe Life and related companies with MarketBeat.com's FREE daily email newsletter.